Skip to content

    JTEKT India

    JTEKTINDIAGood
    Automobile and Auto Components·29 May 2025
    Management Summary

    JTEKT India reported a robust 7% sales growth for FY25, surpassing market trends, despite a notable decline in EBITDA margins to 7.6% due to various external and one-off factors like reduced export sales and quality recalls. The company is aggressively investing in capacity expansion with a Rs. 760 crore CAPEX plan over three years, targeting 100% utilization by March 2027. Strategic moves include becoming a 100% supplier for Maruti's new EV model and aiming for significant CVJ market share growth, positioning India as a global manufacturing hub.

    Highlights

    8
    • JTEKT India achieved a sales growth of 7% for FY25, outperforming the passenger vehicle market growth of 3.7%.

    • EBITDA margins declined from 9.5% in FY24 to 7.6% in FY25, primarily due to external uncontrollable factors.

    • The company incurred a total CAPEX of Rs. 287 crores in FY25, with Rs. 191 crore allocated to new capacity expansion.

    • Export sales share in overall sales reduced from 4% to 2.4% in FY25, impacting margins by 0.6%.

    • Management outlined a 3-year CAPEX plan totaling Rs. 760 crores, with Rs. 430 crores dedicated to capacity expansion.

    • JTEKT India is a 100% supplier for Maruti's upcoming EV model, providing manual gear, CPS, and CVJ.

    • Current capacity utilization for CPS is ~110% and MS gear is ~92%, with a target to reach 100% utilization across facilities by March 2027.

    • The company aims to increase its CVJ market share from ~5% to 7.5-10% within a year or so.

    Concerns

    1
    • External uncontrollable factors impacting margins

    What Changed1

    vs Q2 FY26

    Risks discussed5 → 4 (-1)

    Key financials

    Single quarter

    06 metrics
    1. 01Sales Growth7.0%
    2. 02EBITDA Margin7.6%-20%YoY
    3. 03CAPEX₹287 Cr+66.9%YoY
    4. 04Employee Cost % of Sales10.4%+3.0%YoY
    5. 05Administration Cost455 Mn-7.9%YoY

    Guidance & targets

    13
    CategoryTargetPriority
    Capex
    Total CAPEX
    Rs. 760 crores
    High
    Capex
    Capacity Expansion CAPEX
    Rs. 430 crores
    High
    Capex
    Gujarat Facility Total Project Cost
    Rs. 650 crores
    High
    Capacity
    CPS Production Capacity
    15 lakh units
    High
    Capacity
    Dharuhera Manual Gear Production Capacity
    29 lakh units
    High
    Capacity
    Total Manual Gear Production Capacity
    36 lakh units
    High
    Capacity
    CVJ Line CAPEX
    Rs. 90 to Rs. 100 crores
    High
    Capacity
    Overall Capacity Utilization
    100%
    High
    Market Share
    CVJ Market Share
    7.5-10%
    Medium
    Volume
    India Auto Market Sales
    5 million
    Medium
    Exports
    Export Share in Overall Sales
    4-6%
    Low
    Profitability
    Margins
    improve
    Medium
    Headcount
    Employee Costs
    reduce
    Medium

    Risks & concerns

    5
    RiskSeverity

    External uncontrollable factors impacting margins

    Factors like reduced export sales (0.6% margin impact), quality defects/product recall (0.3% margin impact), and increased process costs/vendor price increases (0.4% margin impact) significantly pressured EBITDA margins.Management acknowledged

    high

    Delays in new model launches and export orders

    The launch of a new Maruti Suzuki model was delayed by almost 6 months, and an export order from Brazil was also slightly delayed, impacting initial capacity utilization.Management acknowledged

    medium

    Initial capacity underutilization for new lines

    While new capacity is being added, initial utilization for lines like CVJ is 65-70%, with full utilization expected to ramp up over time, reaching 100% by March 2027.Management acknowledged

    medium

    Impact of actuarial valuation changes

    A reduction in the discount rate for actuarial valuation from 7% to 6.5% increased future liability, impacting employee costs.Management acknowledged

    low

    Areas of Evasion(1)

    • Specific long-term export percentage targets beyond the near-term directional guidance.

    Q&A highlights

    3

    “So for '24-'25, the company incurred a total CAPEX of Rs. 287 crores, primarily towards expanding production capacity... Assuming Rs. 300 crores of capital expenditure for next year, we will end up with about Rs. 760 crores of CAPEX over the 3 years period.”

    Management provided a detailed breakdown of current and future CAPEX, explaining the allocation for capacity expansion and linking it to the parent company's broader investment plans for India, offering clarity on growth drivers.

    asked by Aman Vora

    3 min read5 chapters

    Detailed Narrative

    01

    Q4 FY25 Financial Performance and Margin Pressures

    JTEKT India reported a 7% sales growth for FY25, outperforming the passenger vehicle market's 3.7% growth. However, EBITDA margins saw a significant decline from 9.5% in FY24 to 7.6% in FY25. This compression was attributed to several external and one-off📎 factors, including a 0.6% margin reduction from decreased export sales, a 0.3% impact from product recalls affecting 2,500 units, and a 0.4% impact from increased process costs and vendor price adjustments. Employee costs as a percentage of sales also rose slightly to 10.4% from 10.1% in the prior year, while administration costs were contained at Rs. 455 million, down from Rs. 494 million.

    02

    Strategic CAPEX and Capacity Expansion Plans

    The company incurred a CAPEX of Rs. 287 crores in FY25, with Rs. 191 crore dedicated to new capacity. Looking ahead, JTEKT India plans a total CAPEX of Rs. 760 crores over the next three years (FY25-FY27), of which Rs. 430 crores will be for capacity expansion. This includes increasing CPS production capacity from 10 lakh to 15 lakh units and manual gear capacity from 24 lakh to 29 lakh units at Dharuhera, ultimately targeting 36 lakh units total. A new CVJ line, requiring Rs. 90-100 crores, is expected to be operational by July 2025. The Gujarat facility, near the Suzuki plant, is projected to cost around Rs. 650 crores and will start operations by FY27-28.

    03

    CVJ Business Growth and Market Share Aspirations

    JTEKT India is actively expanding its Constant Velocity Joint (CVJ) business, currently holding about 5% market share. The company aims to increase this to 7.5-10% within the next year or so. Current CVJ capacity utilization stands at 65-70%, with 2.7 lakh units sold and 1.35 lakh sets of CVJ in FY25. Management expects utilization to improve significantly with new model integrations and export orders. The company is a 100% supplier for Maruti Suzuki's upcoming EV model, providing manual gear, CPS, and CVJ components, with lines ready for production expected to commence exports by July.

    04

    India as a Global Hub and Export Strategy

    JTEKT Corp's global restructuring emphasizes strengthening Indian sites, positioning India as a global manufacturing hub. JTEKT India secured an export order for manual gear from JTEKT Brazil, a group entity. While export sales share declined to 2.4% in FY25, management aims to increase this to 4-6% in the future, driven by strong supply chain management and demand for global models manufactured in India. The new Gujarat facility is also expected to support this export-oriented strategy, particularly for the western region.

    05

    Cost Optimization and Profitability Improvement Initiatives

    Despite the margin pressures in FY25, management is confident in improving profitability. They highlighted containing administration costs at Rs. 455 million and expect employee costs to reduce next year through optimization plans. Initiatives include localization of components like the drive shaft XL for CVJ, production rationalization by shifting jacket assembly to the Bawal plant, and continuous cost optimization involving vendors. The company also noted that new CVJ products for bigger vehicles are expected to have better margins due to different technology and pricing.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.